SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank83
5Y CAGR-62.5%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-62.5%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 11.20% |
| 2024 | -130.42% |
| 2023 | -107.31% |
| 2022 | -65.20% |
| 2021 | 7.21% |
| 2020 | 1504.82% |
| 2019 | 0.00% |